It could potentially be $2 million a year, in which case it's overvalued now. Or it could be $40 million, in which case we're severely undervalued.
You are correct if we were in a world of all stock market truth, justice and fair play. Ever notice how some absolute junk companies trade at a much higher cap than a profitable company growing nicely.
The market is all, and I mean all smoke and mirrors. Nothing really matters except the value of your trading account. Trade the smoke.
Esmaili's contacts in the sports world helped get the cream into locker rooms. Now Esmaili and Smith hope they've earned the cachet to go after the $273 million market for topical analgesic creams. "We are hoping for a trickle-down effect," Esmaili says. "Athletes don't corner the market on aches and pains."
P.S. It's had 10 years of growth since this article. I suspect revenues are in the millions.